You are currently viewing AI In Genomics Market Trends 2026: Spotlight On Innovative Technologies Transform Drug Discovery And Genetic Disease Research
AI In Genomics Market Analysis

With a focus on actionable insights and strategic value, The Business Research Company’s 2026 market reports include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.

AI In Genomics Market Size Analysis: Historical Growth And Future Revenue Projections

The AI in genomics market has observed significant expansion in recent years. Its size is expected to increase from $1.51 billion in 2025 to $2.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 44.6%. This historical development can be attributed to factors such as the growing availability of extensive genomic datasets, the decreasing cost of DNA sequencing technologies, the expansion of genomics research initiatives, strengthening collaborations between AI developers and biotech firms, and advancements in computational biology capabilities.

The AI in genomics market size is projected to experience substantial growth in the upcoming years. It is forecast to reach $9.32 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 43.7%. This expansion during the forecast period is fueled by the increasing adoption of precision medicine approaches, rising investments in AI-powered drug discovery, the broadening of population genomics projects, a growing demand for personalized healthcare solutions, and continuous advancements in deep learning genomic models. Key trends in the forecast period encompass the increasing integration of AI-driven genome analysis platforms, a rising application of machine learning for variant detection, the expanding incorporation of AI in gene editing workflows, the growth of cloud-based genomic data processing, and an enhanced emphasis on high-accuracy pattern recognition.

Preview The AI In Genomics Market Report With A Free Sample:

https://thebusinessresearchcompany.com/sample_request?id=97991370&type=smp&name=AI%20In%20Genomics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

AI In Genomics Market Drivers: What Is Fueling Demand Through 2030?

The expanding application of personalized medicine techniques is projected to fuel the growth of AI in the genomics market going forward. This innovative approach to medical treatment and healthcare, also termed precision medicine, considers individual differences in patients’ genes, surroundings, and lifestyles. The increasing acceptance of personalized medicine is due to the rising occurrence of chronic and complex illnesses, as these methods enable customized treatments for individual patient profiles, thereby enhancing effectiveness and minimizing negative side effects. Within genomics, AI speeds up the examination of intricate genetic data, facilitating personalized medicine through the customization of treatments and interventions based on an individual’s distinct genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from 6 in 2022. Consequently, the expanding utilization of personalized medicine approaches is driving the AI in genomics market.

AI In Genomics Market Segmentation Analysis: Core Categories And Subcategories

The AI in genomics market covered in this report is segmented –

1) By Component: Hardware, Software, Services

2) By Technology: Machine Learning, Computer Vision

3) By Functionality: Genome Sequencing, Gene Editing, Other Functionalities

4) By Application: Drug Discovery And Development, Precision Medicine, Diagnostics, Other Applications

5) By End-Use: Pharmaceutical And Biotech Companies, Healthcare Providers, Research Centers, Other End-Users

Subsegments:

1) By Hardware: Servers, Storage Devices, Networking Equipment

2) By Software: Data Analysis Software, Machine Learning Algorithms, Visualization Tools, Genomic Data Management Software

3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Analytics Services

Which Trends Will Define The AI In Genomics Market Through 2030?

Major companies in the AI in genomics market are concentrating on developing innovative solutions, such as drug discovery platforms, to enhance precision healthcare and research efficiency. A drug discovery platform is a technology or software system that utilizes computational tools, AI, or lab automation to efficiently identify, design, and optimize new drug candidates. For instance, in March 2023, Genomic Vision, a France-based biotechnology company specializing in the development of diagnostic solutions for genetic diseases and cancers, launched FiberSmart, an AI-powered software that enables the high-resolution visualization and analysis of long DNA fibers. This software possesses the potential to profoundly alter the diagnosis and treatment of genetic illnesses. It was introduced to increase the precision and effectiveness of diagnosing and treating genetic diseases. This technology analyzes vast quantities of data to discover patterns and insights that would be impossible for humans to identify independently.

AI In Genomics Market Major Companies And Industry Participants

Major companies operating in the AI in genomics market are International Business Machines Corporation; Microsoft Corp.; NVIDIA Corporation; Deep Genomics Inc.; BenevolentAI Ltd.; Fabric Genomics Inc.; Verge Genomic Inc.; Freenome Holdings Inc.; MolecularMatch Inc.; SOPHiA GENETICS SA; Data4Cure Inc.; PrecisionLife Ltd.; Genoox Ltd.; Lifebit Ltd.; Empiric Logic Ltd.; FDNA Inc.; DNAnexus Inc.; Engine Biosciences Pte Ltd.; 4baseCare; Congenica Ltd.; CytoReason Ltd.; Emedgene Technologies LTD; Illumina Inc.; Lifebit Biotech Ltd.; Mendel.ai; Predictive Oncology Inc.; Tempus Labs Inc.; 10x Genomics Inc.; Repositive Limited; Genedata AG; Global Gene Corp; Nference Inc.; Bluebee Holding B.V.; Genomenon Inc.

Buy The Full AI In Genomics Global Market Report 2026:

https://thebusinessresearchcompany.com/report/AI-in-genomics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

AI In Genomics Market Geographic Analysis: Which Region Accounts For The Biggest Share?

North America was the largest region in the AI in genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the AI in the genomics market report during the forecast period. The regions covered in the AI in genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model